scispace - formally typeset
Journal ArticleDOI

"Pediatric-type" gastrointestinal stromal tumors are SDHB negative ("type 2") GISTs.

Reads0
Chats0
TLDR
Detailed hematologic presentation of autoimmune gastritis in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting and the relationship between pernicious anemia and iron deficiency is described.
Abstract
REFERENCES 1. Abraham SC, Montgomery EA, Singh VK, et al. Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol. 2002;26:1276–1285. 2. Hershko C, Ronson A, Souroujon M, et al. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107:1673–1679. 3. Lagarde S, Jovenin N, Diebold MD, et al. Is there any relationship between pernicious anemia and iron deficiency? Gastroenterol Clin Biol. 2006;30:1245–1249. 4. Park JY, Cornish TC, Lam-Himlin D, et al. Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting. Am J Surg Pathol. 2010;34:1591–1598.

read more

Citations
More filters
Journal ArticleDOI

Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone.

TL;DR: Changes in the classification of soft tissue and bone sarcomas as well as tumors of intermediate biologic potential in the 2013 World Health Organization volume are reviewed, new molecular insights into these tumors, and associated surgical and clinical implications are reviewed.
Journal ArticleDOI

Refinements in Sarcoma Classification in the Current 2013 World Health Organization Classification of Tumours of Soft Tissue and Bone

TL;DR: The fourth edition of the World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone was published in February 2013 and provides an updated classification scheme and reproducible diagnostic criteria, based on recent clinicopathologic studies and genetic and molecular data.
Journal ArticleDOI

Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.

TL;DR: Although this tumor may undergo dedifferentiation and metastasize, sometimes after a prolonged delay, metastatic disease is rare in the absence of high-grade nuclear atypia or coagulative necrosis and showing a strong relationship with SDH germline mutation.
Journal ArticleDOI

Gastrointestinal Stromal Tumors

TL;DR: Tyrosine kinase inhibitor (TKI) therapy has led to substantial improvements in survival, both for patients with localized GIST and those with advanced disease, and imatinib is usually the best tolerated of the three and the standard first-line treatment.
Journal ArticleDOI

Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia

TL;DR: Positive immunohistochemical staining for the SDHB subunit identifies PHEO/PGL associated with germline mutation of any of the mitochondrial complex 2 components and can be used to triage formal genetic testing of all PHEO /PGL for SDH mutations.
References
More filters
Journal ArticleDOI

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

TL;DR: Phaeochromocytoma-paraganglioma syndrome can be diagnosed reliably by an immunohistochemical procedure and SDHB immunohistsochemistry could improve the diagnosis, according to a large retrospective and prospective tumour series.
Journal ArticleDOI

Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases.

TL;DR: None of the 16 tumors from 15 patients had a KIT exon 9, 11, 13, or 17 or PDGFRA exon 12 or 18 mutation as is typically seen in sporadic GISTs, indicating that GISTS in NF1 patients have a different pathogenesis than sporadic Gists.
Journal ArticleDOI

Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors

TL;DR: In vitro drug screening showed that second-generation kinase inhibitors may provide greater clinical benefit in pediatric GIST, and Pediatric GISTs show distinct transcriptional signature, suggesting a different biology than WT GIST in adults.
Related Papers (5)